Deal could be among year’s largest private equity buyouts as contact-lens maker looks to split from indebted parent
Contact lens supplier is looking for buyers to separate from indebted parent company
Eyecare company’s plans to raise up to $840mn in second-largest listing of the year stymied by volatile markets
Rising interest rates and stock market sell-off should continue to give investors pause
Pharmaceutical company formerly known as Valeant keeps shedding assets from past deal spree
The need to understand customers led to an extreme product test for the dealmaking pharma boss
A pharma deal with some wrinkles to smooth out to prolong the life of cash flows
As Europe changes austerity tactics, pharma and telecom M&A deals dominate
Warburg will get up to about three times its initial equity investment
Warburg Pincus’s audacity and opportunism is rewarded
